Every once in a while, an opportunity comes along that embodies all the best parts of medicine. Recording a @StoryCorps interview with mentor and friend @EricKleinMD is one of those moments. Eric - thank you so much for the invitation 🙏 @CleClinicUro
https://t.co/jUMJiECAF2
New results provide estimates for average ctDNA detectable sojourn time in tumors across multiple cancer sites and stages and can inform the design of future screening studies for multicancer early detection.
https://t.co/dM3Tok8a1d
@OncoAlert#MCED#MCD#CancerDetection
As coaches, words are our most powerful tool.
We need to make sure we maximize their effectiveness.
We need to be excellent teachers, not just good motivators.
This quick guide ensures you have the tools to do that at a high level.
Winning any award is special, but being recognized by mentors, colleagues, and friends as the 2025 @ASRM_org@ReproMed_SMRU Young Investigator of the Year is truly magical. Huge thanks to @CleClinicUro trainees for the hard work and to @MOBYUSgroup for taking a leap of faith 🥹
GUKI party ☀️, graduation, the greatest award of my life FOTY, celebrating the end of 8️⃣ yrs of training @CleClinicUro
“Great great great” as @SCampbellMDPhD would say
Thanks Steve for being a superb person, surgeon, educator, colleague and program director; and for donating your progeny to Urology! Wishing you continued success in your new role
High grade prostate cancers may not make much PSA so his recent PSAs may not have been worrisome. And DRE has fallen out of favor as a screening tool, but this case demonstrates it still has value.
Big fan of the retrosigmoid ileal conduit (MOSAIC) in radiated patients especially when the left ureter is compromised/short. Elegant solution, great outcomes, no reabsorption toxicity. #bladdercancer Some light reading here 📖➡️https://t.co/Dkbps2cLlB #bladdercancer@EurUrolOpen